Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$21.54 - $24.41 $132 Million - $150 Million
-6,144,638 Reduced 99.85%
8,959 $202,000
Q2 2023

Aug 11, 2023

BUY
$12.62 - $24.47 $1.7 Million - $3.3 Million
134,925 Added 2.24%
6,153,597 $151 Million
Q1 2023

May 12, 2023

BUY
$12.98 - $17.1 $70.1 Million - $92.4 Million
5,401,134 Added 874.62%
6,018,672 $81 Million
Q4 2022

Feb 13, 2023

BUY
$13.92 - $17.0 $8.6 Million - $10.5 Million
617,538 New
617,538 $9.61 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.